These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 14967728

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.
    Pratt CM, Singh SN, Al-Khalidi HR, Brum JM, Holroyde MJ, Marcello SR, Schwartz PJ, Camm AJ, ALIVE Investigators.
    J Am Coll Cardiol; 2004 Apr 07; 43(7):1211-6. PubMed ID: 15063432
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
    Pritchett EL, Kowey P, Connolly S, Page RL, Kerr C, Wilkinson WE, A-COMET-I Investigators.
    Am Heart J; 2006 May 07; 151(5):1043-9. PubMed ID: 16644334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.
    Pritchett EL, Page RL, Connolly SJ, Marcello SR, Schnell DJ, Wilkinson WE.
    J Am Coll Cardiol; 2000 Sep 07; 36(3):794-802. PubMed ID: 10987602
    [Abstract] [Full Text] [Related]

  • 10. Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
    Pritchett EL, Schulte MC, Schnell D, Marcello SR, Wilkinson WE, Page RL, Connolly SJ, Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.
    J Clin Pharmacol; 2002 Apr 07; 42(4):388-94. PubMed ID: 11936563
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM, Leunissen JD, Wellens HJ, Vos MA.
    Eur J Pharmacol; 2001 Jan 19; 412(1):67-76. PubMed ID: 11166738
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
    Page RL, Pritchett EL, Connolly S, Wilkinson WE, SVA-4 Investigators.
    J Cardiovasc Electrophysiol; 2008 Feb 19; 19(2):172-7. PubMed ID: 17916138
    [Abstract] [Full Text] [Related]

  • 20. Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.
    Connolly SJ, Schnell DJ, Page RL, Wilkinson WE, Marcello SR, Pritchett EL.
    Am J Cardiol; 2001 Nov 01; 88(9):974-9. PubMed ID: 11703992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.